We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Converted TKA Far Riskier Than Primary TKA

By HospiMedica International staff writers
Posted on 10 Dec 2019
Revision risk for total knee arthroplasty (TKA) converted from unicompartmental knee arthroplasty (UKA) is three times higher than primary TKA, according to a new study.

Researchers at Aalborg University Hospital (Denmark) conducted a study to compare conversion to TKA when UKA fails to primary TKA. More...
The researchers analyzed the Danish Knee Arthroplasty Registry from 1997 to 2017, comparing 1,012 TKAs converted from UKAs to 73,819 primary TKAs, and to 2,572 revision TKAs. The primary outcome was the risk of revision, with secondary outcomes including the influence of different knee implants, the indication for the UKA conversion, and surgical volume on the survival of TKA converted from UKA.

The results revealed that patients who underwent TKA converted from UKA were younger than those who underwent primary or revision TKA, and also had less severe knee-joint degeneration (based on Charnley class). For patients who underwent conversion of UKA to TKA, long-term outcomes were similar to those who underwent revision TKA, with both groups showing an estimated 15-year implant survival rate of 78%. In contrast, the 15-year implant survival rate for primary TKA was 94%.

After adjustment, the risk of revision was three times higher for patients who underwent UKA-to-TKA conversion compared with primary TKA. The researchers also showed that implant type did not affect outcomes for patients who underwent conversion of UKA to TKA. Converted UKAs were mainly mobile-bearing (85%), and the main reasons for UKA conversion were implant loosening, unexplained pain, and progression of arthritis. The study was published on November 20, 20189, in The Journal of Bone and Joint Surgery.

“TKA converted from medial UKA has a threefold higher risk of revision when compared with primary TKA. Implant survival resembled that of revision TKA, but with a higher prevalence of unexplained pain and instability,” concluded lead author Anders El-Galaly, PhD, of the Orthopaedic Research Unit, and colleagues. “We believe that careful consideration is necessary before using medial UKA as treatment for knee osteoarthritis, as a potential conversion to a TKA decreased implant survival when compared with that following primary TKA.”

TKA is an orthopedic surgical procedure where the articular surfaces of the knee joint--the femoral condyles and tibial plateau--are replaced. There is at least one polyethylene insert between the tibia and the femur that serves as a shock absorber; in 50% of the cases, the patella is also replaced in order to restore the extensor mechanism. The level of bone loss will dictate which kind of patella prosthesis is placed.

Related Links:
Aalborg University Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.